title: Efficient differentiation of human induced pluripotent stem cells generates cardiac cells that provide protection following myocardial infarction in the rat.
abstract: Induced pluripotent stem (iPS) cells are being used increasingly to complement their embryonic counterparts to understand and develop the therapeutic potential of pluripotent cells. Our objectives were to identify an efficient cardiac differentiation protocol for human iPS cells as monolayers, and demonstrate that the resulting cardiac progenitors could provide a therapeutic benefit in a rodent model of myocardial infarction. Herein, we describe a 14-day protocol for efficient cardiac differentiation of human iPS cells as a monolayer, which routinely yielded a mixed population in which over 50% were cardiomyocytes, endothelium, or smooth muscle cells. When differentiating, cardiac progenitors from day 6 of this protocol were injected into the peri-infarct region of the rat heart; after coronary artery ligation and reperfusion, we were able to show that human iPS cell-derived cardiac progenitor cells engrafted, differentiated into cardiomyocytes and smooth muscle, and persisted for at least 10 weeks postinfarct. Hearts injected with iPS-derived cells showed a nonsignificant trend toward protection from decline in function after myocardial infarction, as assessed by magnetic resonance imaging at 10 weeks, such that the ejection fraction at 10 weeks in iPS treated hearts was 62%±4%, compared to that of control infarcted hearts at 45%±9% (P<0.2). In conclusion, we demonstrated efficient cardiac differentiation of human iPS cells that gave rise to progenitors that were retained within the infarcted rat heart, and reduced remodeling of the heart after ischemic damage.
authors.affiliation: Stem Cell Research Laboratory, NHS Blood and Transplant, John Radcliffe Hospital, Headington, Oxford, United Kingdom. lee.carpenter@nhsbt.nhs.uk
authors.forename: Lee
authors.initials: L
authors.lastname: Carpenter
authors.forename: Carolyn
authors.initials: C
authors.lastname: Carr
authors.forename: Cheng Tao
authors.initials: CT
authors.lastname: Yang
authors.forename: Daniel J
authors.initials: DJ
authors.lastname: Stuckey
authors.forename: Kieran
authors.initials: K
authors.lastname: Clarke
authors.forename: Suzanne M
authors.initials: SM
authors.lastname: Watt
mesh_terms: D000818:Animals; D002454:Cell Differentiation; D006801:Humans; D057026:Induced Pluripotent Stem Cells / Q000166:cytology* / Q000637:transplantation; D008279:Magnetic Resonance Imaging; D009203:Myocardial Infarction / Q000628:therapy*; D009206:Myocardium / Q000166:cytology*; D051381:Rats; D012038:Regeneration; D044968:Regenerative Medicine / Q000379:methods; D033581:Stem Cell Transplantation; D014183:Transplantation, Heterologous; D016896:Treatment Outcome